NCT03080883 2025-05-18
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
Phase 3 Completed
Academic and Community Cancer Research United
Academic and Community Cancer Research United
Daiichi Sankyo
Rovi Pharmaceuticals Laboratories
Ontario Clinical Oncology Group (OCOG)